Trials / Completed
CompletedNCT02986529
A Study to Assess the Bioavailability of Oral Sodium Oligo-mannurarate (GV-971) in Healthy Chinese Male Subjects
A Double-blind, Randomized, Three-period, Three-way Crossover Design, Placebo Controlled Single Dose Study to Assess the Bioavailability of Sodium Oligo-mannurarate (GV-971) Capsule 150 mg, 300mg, 450mg in Healthy Chinese Male Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 15 (actual)
- Sponsor
- Shanghai Greenvalley Pharmaceutical Co., Ltd. · Industry
- Sex
- Male
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
To evaluate the Bioavailability for GV-971 capsules of 150 mg, 300mg, and 450mg after administration of single oral doses of 900mg in healthy Male subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | GV-971 | |
| DRUG | Placebos |
Timeline
- Start date
- 2016-11-01
- Primary completion
- 2017-02-24
- Completion
- 2017-11-01
- First posted
- 2016-12-08
- Last updated
- 2018-02-07
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT02986529. Inclusion in this directory is not an endorsement.